Santangelo, G.; Moscardelli, S.; Barbieri, L.; Faggiano, A.; Carugo, S.; Faggiano, P. Aortic Valve Stenosis and Cancer: Problems of Management. J. Clin. Med.2023, 12, 5804.
Santangelo, G.; Moscardelli, S.; Barbieri, L.; Faggiano, A.; Carugo, S.; Faggiano, P. Aortic Valve Stenosis and Cancer: Problems of Management. J. Clin. Med. 2023, 12, 5804.
Santangelo, G.; Moscardelli, S.; Barbieri, L.; Faggiano, A.; Carugo, S.; Faggiano, P. Aortic Valve Stenosis and Cancer: Problems of Management. J. Clin. Med.2023, 12, 5804.
Santangelo, G.; Moscardelli, S.; Barbieri, L.; Faggiano, A.; Carugo, S.; Faggiano, P. Aortic Valve Stenosis and Cancer: Problems of Management. J. Clin. Med. 2023, 12, 5804.
Abstract
Aortic valve stenosis and malignancy frequently coexist and share the same risk factors as atherosclerotic disease. Data reporting the prognosis of patients with severe aortic stenosis and cancer are limited. Tailoring the correct and most optimal care for cancer patients with severe aortic stenosis is complex. Cancer patients may be further disadvantaged by aortic stenosis if it interferes with their treatment by increasing the risk associated with oncologic surgery and compounding the risks associated with cardiotoxicity and heart failure (HF). Nowadays, several therapeutic options are available for aortic valve stenosis (surgical valve replacement , transcatheter valve implantation, balloon valvuloplasty, or medical therapy), but in presence of malignancy, the use of one of these versus the others should be decided on a case-by-case approach, depending on cancer stage and associated treatment, expected outcome, comorbidities and after an accurate physical examination and Doppler-echocardiography which are the key tools for diagnosing and evaluating aortic stenosis. The current review considers the available data on the association between aortic stenosis and cancer, and therapeutic options.
Public Health and Healthcare, Public Health and Health Services
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
